Intravitreal Ranibizumab in Exudative Age-related Macular Degeneration With Posterior Vitreomacular Adhesion
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 26, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 26, 2015Completed
Condition(s):Neovascular Age-Related Macular DegenerationLast Updated:December 20, 2019Completed
Condition(s):Neovascular Age-related Macular Degeneration; Retinal Disease; Retinal Degeneration; Macular DegenerationLast Updated:October 31, 2022Terminated
Condition(s):Neovascular Age-related Macular Degeneration; Diabetic Macular EdemaLast Updated:February 5, 2024Recruiting
Condition(s):Macular DegenerationLast Updated:March 26, 2014Completed
Condition(s):Neovascular Age-related Macular Degeneration; Diabetic Macular EdemaLast Updated:July 27, 2023Suspended
Condition(s):Macular DegenerationLast Updated:July 24, 2023Completed
Condition(s):Neovascular Age-related Macular Degeneration; Diabetic Macular EdemaLast Updated:February 9, 2023Completed
Condition(s):Neovascular Age-related Macular DegenerationLast Updated:January 9, 2024Recruiting
Condition(s):Age-related Macular DegenerationLast Updated:March 25, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.